Aigen Investment Management, LP Illumina, Inc. Transaction History

Aigen Investment Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$101.05 - $133.57 $707,147 - $934,722	6,998 New	6,998 $730,000
Q4 2023 Feb 09, 2024	BUY	$92.79 - $142.53 $328,291 - $504,271	3,538 Added 214.55%	5,187 $722,000
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $212,572 - $317,333	1,649 New	1,649 $226,000
Q2 2022 Aug 02, 2022	BUY	$181.58 - $368.0 $1.16 Million - $2.35 Million	6,382 New	6,382 $1.18 Million
Q1 2022 May 05, 2022	SELL	$303.87 - $423.8 $701,028 - $977,706	-2,307 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$347.28 - $421.83 $393,468 - $477,933	1,133 Added 96.51%	2,307 $824,000
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $476,186 - $616,162	1,174 New	1,174 $476,000
Q2 2021 Aug 10, 2021	SELL	$372.84 - $481.5 $759,475 - $980,815	-2,037 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$361.28 - $504.76 $735,927 - $1.03 Million	2,037 New	2,037 $782,000
Q2 2020 Aug 10, 2020	SELL	$256.46 - $373.01 $772,457 - $1.12 Million	-3,012 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$209.2 - $335.53 $630,110 - $1.01 Million	3,012 New	3,012 $823,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.